Inclusion Criteria:  A person is eligible for inclusion in the study if he/she:  Is at least 18 years of age and has full legal capacity to volunteer. Has read, understood, and signed the information consent letter. Has been diagnosed with dry eyes. Has reduced tear break up time (NITBUT) and/or reduced tear meniscus height (TMH), clinical sign of dry eye disease and contact lens discomfort or is symptomatic of dry eye. Is willing and able to follow instructions and maintain the appointment schedule. Has greater than 13 points on the OSDI. Has greater than 4 points on the Standardized Patient Evaluation of Eye Dryness (SPEED).  Exclusion Criteria:  A person will be excluded from the study if he/she:  Is using any topical medications that will likely affect the study outcome. Has undergone any form of corneal surgery. Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study. Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye not related to the signs of dry eye. Has any clinically significant lid or conjunctival abnormalities and active neovascularization on the cornea. Anatomic variations of the conjunctiva that can impair proper scleral or soft contact lens wear/fitting Ocular pathology other than dry eye (e.g. glaucoma, macular degeneration) which may significantly impact visual function and assessment. Is participating in any other type of eye related clinical or research study. Has any active ocular infection and may require topical medications. Currently taking any systemic medication that may affect the study outcome. Is pregnant Has been diagnosed, recovered, or tested positive but asymptomatic with COVID-19.